BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22819581)

  • 1. Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis.
    Laymon CM; Oborski MJ; Lee VK; Davis DK; Wiener EC; Lieberman FS; Boada FE; Mountz JM
    Magn Reson Imaging; 2012 Nov; 30(9):1268-78. PubMed ID: 22819581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging.
    Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Reardon DA; Coleman RE
    Mol Imaging Biol; 2006; 8(6):340-7. PubMed ID: 17051323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.
    Brahm CG; den Hollander MW; Enting RH; de Groot JC; Solouki AM; den Dunnen WFA; Heesters MAAM; Wagemakers M; Verheul HMW; de Vries EGE; Pruim J; Walenkamp AME
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2404-2412. PubMed ID: 30032322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
    Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.
    Corroyer-Dulmont A; Pérès EA; Gérault AN; Savina A; Bouquet F; Divoux D; Toutain J; Ibazizène M; MacKenzie ET; Barré L; Bernaudin M; Petit E; Valable S
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):682-94. PubMed ID: 26537287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.
    Collet S; Valable S; Constans JM; Lechapt-Zalcman E; Roussel S; Delcroix N; Abbas A; Ibazizene M; Bernaudin M; Barré L; Derlon JM; Guillamo JS
    Neuroimage Clin; 2015; 8():448-54. PubMed ID: 26106569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of [
    Shymanskaya A; Worthoff WA; Stoffels G; Lindemeyer J; Neumaier B; Lohmann P; Galldiks N; Langen KJ; Shah NJ
    Mol Imaging Biol; 2020 Feb; 22(1):198-207. PubMed ID: 30989437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
    Nedergaard MK; Michaelsen SR; Perryman L; Erler J; Poulsen HS; Stockhausen MT; Lassen U; Kjaer A
    Nucl Med Biol; 2016 Mar; 43(3):198-205. PubMed ID: 26924500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of meningioma with 18F-FLT: a predictor of tumour progression.
    Bashir A; Vestergaard MB; Marner L; Larsen VA; Ziebell M; Fugleholm K; Law I
    Brain; 2020 Dec; 143(11):3308-3317. PubMed ID: 33141151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma.
    Yaghoubi SS; Jensen MC; Satyamurthy N; Budhiraja S; Paik D; Czernin J; Gambhir SS
    Nat Clin Pract Oncol; 2009 Jan; 6(1):53-8. PubMed ID: 19015650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ²³Na-MRI of recurrent glioblastoma multiforme after intraoperative radiotherapy: technical note.
    Haneder S; Giordano FA; Konstandin S; Brehmer S; Buesing KA; Schmiedek P; Schad LR; Wenz F; Schoenberg SO; Ong MM
    Neuroradiology; 2015 Mar; 57(3):321-6. PubMed ID: 25428586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can an ¹⁸F-ALF-NOTA-PRGD2 PET/CT Scan Predict Treatment Sensitivity to Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?
    Zhang H; Liu N; Gao S; Hu X; Zhao W; Tao R; Chen Z; Zheng J; Sun X; Xu L; Li W; Yu J; Yuan S
    J Nucl Med; 2016 Apr; 57(4):524-9. PubMed ID: 26514171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns.
    Chandrasekaran S; Hollander A; Xu X; Benci JL; Davis JJ; Dorsey JF; Kao G
    ScientificWorldJournal; 2013; 2013():796029. PubMed ID: 23690748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANG1005 for breast cancer brain metastases: correlation between
    O'Sullivan CC; Lindenberg M; Bryla C; Patronas N; Peer CJ; Amiri-Kordestani L; Davarpanah N; Gonzalez EM; Burotto M; Choyke P; Steinberg SM; Liewehr DJ; Figg WD; Fojo T; Balasubramaniam S; Bates SE
    Breast Cancer Res Treat; 2016 Nov; 160(1):51-59. PubMed ID: 27620882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.
    Troost EG; Bussink J; Slootweg PJ; Peeters WJ; Merkx MA; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2010 May; 51(5):713-9. PubMed ID: 20395329
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lakomý R; Lojová M; Souckova L; Hynkova L; Polachova K; Vasina J; Demlová R; Poprach A; Sana J; Prochazka T; Smrcka M; Fadrus P; Jancalek R; Selingerova I; Belanova R; Slampa P; Pospisil P; Kazda T
    BMC Cancer; 2024 Jun; 24(1):736. PubMed ID: 38879476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.
    Nasseri M; Gahramanov S; Netto JP; Fu R; Muldoon LL; Varallyay C; Hamilton BE; Neuwelt EA
    Neuro Oncol; 2014 Aug; 16(8):1146-54. PubMed ID: 24523362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of 3'-deoxy-3'-
    Sato M; Umeda Y; Tsujikawa T; Mori T; Morikawa M; Anzai M; Waseda Y; Kadowaki M; Kiyono Y; Okazawa H; Ishizuka T
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging.
    Jensen P; Feng L; Law I; Svarer C; Knudsen GM; Mikkelsen JD; de Nijs R; Larsen VA; Dyssegaard A; Thomsen G; Fischer W; Guilloteau D; Pinborg LH
    J Nucl Med; 2015 Sep; 56(9):1386-90. PubMed ID: 26182972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.